Work

Abstract 5556: Development of osimertinib resistant mouse models for preclinical evaluation of third-generation EFGR-TKI therapies

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5556

Authors: Hongyan Sun, Yinuo Wang, Shiying Guo, Jianming Xu, Xiang Gao, Jun Wang

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409630471

Cites:

Cited by:

Related to: 10